Risk Assessment, page-13

First 13 Last

Share
Profile

Follow
mikyc

191 Posts.

41

25/01/24

03:38

Post #: 72054412
Share

Originally posted by stephencca: ↑

great summary!!! There is also the chance the income will grow a lot, lot more..
if you had the rights to particular drugs requiring a prescription and you don’t want to be screwed by the large wholesalers, it may be a very attractive option to use myx’s distribution system. I was surprised to read in a recent report myx we’re working on getting their “system” working properly to facilitate their distribution system. If they get it right and it works very smoothly, their distribution system will attract brands who simply want to profit share with myx. I can conceive of Myx getting offers of profit sharing. They won’t have to buy rights.
something people have forgotten is that a product is useless unless you have the means to sell it. THMD and NEXTSTELLIS are good examples of how difficult it is to get quality products into the market. The barriers are almost insurmountable. Companies with the rights to drugs don’t have many viable/profitable options, if any. You can Set up your own sales force to convince drs to prescribe but you then have to sell it, and get ripped off by a wholesaler. MYX have a system to distribute drugs and share the profits with companies who have patent rights. It’s unlikely small companies with patented product would survive setting up their own distribution infrastructure, so their only option is to be ripped off by large wholesalers. Better to partner with myx.

Expand

steph - this makes sense but can you elaborate more on "distribution infrastructure" of Mayne? what model and how efficient

MYX Price at posting: $5.23 Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

PSC

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

DES

DeSoto lands key exploration rights for Syncerus gold project in Guinea

EMC

Everest Metals dips as company clocks low gold grades at Taipan, WA

LKO

'Rising demand': Lakes Blue Energy starts well-timed Wombat-5 gas drilling

I88

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

First 13 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.02		Change 0.070(1.41%)		Mkt cap ! $408.6M

Open	High	Low	Value	Volume
$4.97	$5.04	$4.95	$378.3K	75.94K

Buyers (Bids)

No.	Vol.	Price($)
12	948	$5.02

Sellers (Offers)

Price($)	Vol.	No.
$5.03	347	4

View Market Depth

No.	Vol.	Price($)
12	948	5.020
9	3016	5.010
5	918	5.000
6	1362	4.990
9	2139	4.980

Price($)	Vol.	No.
5.030	347	4
5.040	3768	5
5.050	939	2
5.060	1216	4
5.070	2569	3

Last trade - 13.55pm 01/08/2025 (20 minute delay)

MYX (ASX) Chart

Risk Assessment, page-13

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

DeSoto lands key exploration rights for Syncerus gold project in Guinea

Everest Metals dips as company clocks low gold grades at Taipan, WA

'Rising demand': Lakes Blue Energy starts well-timed Wombat-5 gas drilling

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Risk Assessment, page-13

Top Stories

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

DeSoto lands key exploration rights for Syncerus gold project in Guinea

Everest Metals dips as company clocks low gold grades at Taipan, WA

'Rising demand': Lakes Blue Energy starts well-timed Wombat-5 gas drilling

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News